These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33714841)
1. Human MALT1 deficiency and predisposition to infections. Lu HY; Turvey SE Curr Opin Immunol; 2021 Oct; 72():1-12. PubMed ID: 33714841 [TBL] [Abstract][Full Text] [Related]
2. Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire. Frizinsky S; Rechavi E; Barel O; Najeeb RH; Greenberger S; Lee YN; Simon AJ; Lev A; Ma CA; Sun G; Blackstone SA; Milner JD; Somech R; Stauber T J Clin Immunol; 2019 May; 39(4):401-413. PubMed ID: 31037583 [TBL] [Abstract][Full Text] [Related]
3. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity. Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595 [TBL] [Abstract][Full Text] [Related]
4. MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging. Demeyer A; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Muyllaert D; Staal J; Beyaert R Front Immunol; 2019; 10():2330. PubMed ID: 31632405 [TBL] [Abstract][Full Text] [Related]
5. An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Quancard J; Klein T; Fung SY; Renatus M; Hughes N; Israël L; Priatel JJ; Kang S; Blank MA; Viner RI; Blank J; Schlapbach A; Erbel P; Kizhakkedathu J; Villard F; Hersperger R; Turvey SE; Eder J; Bornancin F; Overall CM Nat Chem Biol; 2019 Mar; 15(3):304-313. PubMed ID: 30692685 [TBL] [Abstract][Full Text] [Related]
6. Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes. Wiegmann H; Reunert J; Metze D; Marquardt T; Engel T; Kunde V; Ehl S; Foell D; van den Heuvel I; Oji V; Wittkowski H Br J Dermatol; 2020 Jan; 182(1):202-207. PubMed ID: 31049936 [TBL] [Abstract][Full Text] [Related]
7. Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency. Monajemi M; Fisk S; Pang YCF; Leung J; Menzies SC; Ben-Othman R; Cai B; Kollmann TR; Rozmus J; Sly LM J Leukoc Biol; 2019 Oct; 106(4):863-877. PubMed ID: 31313375 [TBL] [Abstract][Full Text] [Related]
8. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. Sefer AP; Abolhassani H; Ober F; Kayaoglu B; Bilgic Eltan S; Kara A; Erman B; Surucu Yilmaz N; Aydogmus C; Aydemir S; Charbonnier LM; Kolukisa B; Azizi G; Delavari S; Momen T; Aliyeva S; Kendir Demirkol Y; Tekin S; Kiykim A; Baser OF; Cokugras H; Gursel M; Karakoc-Aydiner E; Ozen A; Krappmann D; Chatila TA; Rezaei N; Baris S J Clin Immunol; 2022 Apr; 42(3):634-652. PubMed ID: 35079916 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. Maródi L; Cypowyj S; Tóth B; Chernyshova L; Puel A; Casanova JL J Allergy Clin Immunol; 2012 Nov; 130(5):1019-27. PubMed ID: 23040277 [TBL] [Abstract][Full Text] [Related]
15. ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency. Roussel L; Vinh DC Curr Opin Immunol; 2021 Oct; 72():21-26. PubMed ID: 33756276 [TBL] [Abstract][Full Text] [Related]
16. A De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M Front Immunol; 2018; 9():2366. PubMed ID: 30429846 [No Abstract] [Full Text] [Related]
17. Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome. Charbit-Henrion F; Jeverica AK; Bègue B; Markelj G; Parlato M; Avčin SL; Callebaut I; Bras M; Parisot M; Jazbec J; Homan M; Ihan A; Rieux-Laucat F; Stolzenberg MC; Ruemmele FM; Avčin T; Cerf-Bensussan N; J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):378-384. PubMed ID: 27253662 [TBL] [Abstract][Full Text] [Related]
18. Germline CBM-opathies: From immunodeficiency to atopy. Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts. Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D Front Immunol; 2020; 11():576651. PubMed ID: 33042160 [TBL] [Abstract][Full Text] [Related]
20. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke. Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]